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ABSTRACT  25 
Background: First-born children are at higher risk for development of a range of immune-26 
mediated diseases. The underlying mechanism of ‘birth-order-effects’ on disease risk is 27 
largely unknown, but in utero programming of the child’s immune system may play a role.  28 
Objective: We studied the association between birth-order and the functional response of 29 
stimulated cord blood T cells.  30 
Method: Purified cord blood T cells were polyclonally activated with anti-CD3/CD28-31 
coated beads in a subgroup of 28 children enrolled in the COPSAC2010 birth cohort. 32 
Expression levels of seven activation markers on helper and cytotoxic T cells as well as the 33 
percentage of CD4+CD25+ T cells were assessed by flow cytometry. Production of IFN-γ, 34 
TNF-α, IL-17, IL-4, IL-5, IL-13 and IL-10 was measured in supernatants.  35 
Results: IL-10 secretion (P = 0.007) and CD25 expression on CD4+ helper T cells (P = 36 
0.0003) in activated cord blood T cells were selectively reduced in first-born children, while 37 
the percentage of CD4+CD25+ cord blood T cells was independent of birth-order. 38 
Conclusion: First-born infants display a reduced anti-inflammatory profile in T cells at 39 
birth. This possible in utero ‘birth-order’ T cell programing may contribute to later 40 
development of immune-mediated diseases by increasing overall immune reactivity in first-41 
born children as compared to younger siblings.    42 
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Clinical Implications or Key Messages 43 
The prenatal period of life is a developmental window in which the fetal T cell immune 44 
response seems to be programmed by maternal parity status.  45 
 46 
Capsule Summary 47 
The authors report a reduced anti-inflammatory bias in the T cell function of first-born child. 48 
This in utero programming of immunosuppressive mechanisms could contribute to birth-49 
order-associated reductions in immune-mediated disease prevalence.     50 
Key words 51 
Parity number, neonates, T cells, immune regulation, in utero programming 52 
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Abbreviations  64 
APC  Allophycocyanin 65 
COPSAC2010  Copenhagen Prospective Studies on Asthma in Childhood 66 
CD:  Cluster of differentiation 67 
CD40L:  CD 40 ligand (CD154)   68 
CTL:  Cytotoxic T lymphocyte 69 
FITC   Fluorescein isothiocyanate 70 
GLM  General linear models 71 
ICOS:  Inducible T cell co-stimulator (CD278) 72 
IFN-γ:  Interferon-γ 73 
IL:   Interleukin 74 
MFI:  Mean fluorescence intensity 75 
PC:  Principal component 76 
PCA:  Principal component analysis 77 
PE:  Phycoerythrin 78 
PC7:  R-phycoerythrin-cyanine 7 79 
PE-Cy7:  PE-Cyanin 7 80 
PHA:  Phytohaemagglutinin 81 
Th:  T helper  82 
TNF-α:  Tumor necrosis factor-α 83 
Tregs:   Regulatory T cells 84 
Tr1:  Type 1 regulatory T cells  85 
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INTRODUCTION 86 
A ‘birth-order-effect’ on disease risk has been known for several decades (1) relating to a 87 
higher risk in the first-born child for a number of diseases including lymphoma (2), testicular 88 
cancer (3,4), type 1 diabetes mellitus (5), eczema, rhinitis and asthma (6–8). Since these 89 
diseases are all influenced by dysfunctional immune activation, we hypothesized that the 90 
birth-order may affect early immune function and be programmed already during pregnancy. 91 
Throughout pregnancy the mother’s immune system is challenged by the hemi-allogeneic 92 
fetus and in order to accomplish a successful pregnancy her immune system is dynamically 93 
modulated from conception to delivery (9). Essential for implantation and maintenance of 94 
pregnancy is several hormones, including estrogen, which presumably promotes expansion 95 
of regulatory T cells (Tregs) and production of anti-inflammatory interleukin-10 (IL-10) 96 
within the mother as well as at the maternal-fetal interface (10–14). It is also reported that 97 
long-lasting fetus-specific immune cells develop in maternal circulation during pregnancy 98 
(15,16) and rapidly expand in secondary pregnancies with the same father (17). An increased 99 
number of Tregs specific for paternal antigens is found in secondary pregnancies (18). All-100 
together this suggests that an increased immune suppression occurs in multiparous women. 101 
In relation to the general maternal-fetal interplay, it is reported that anti-inflammatory, but 102 
not pro-inflammatory, mediator levels correlate between the pregnant mother and her fetus 103 
(19), as does estrogen levels (20). These findings support a bidirectional immunological 104 
reflection of an anti-inflammatory milieu between mother and child. It is, however, unknown 105 
if changes in this maternal-fetal tolerance of newborns with increased birth numbers are a 106 
result of in utero programming of immune function.  107 
We aimed to study if T cell function are differentially encoded in newborns of primiparous 108 
(first pregnancy) and multiparous (second or more pregnancies) mothers. We purified T cells 109 
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from cord blood and stimulated these with anti-CD3/CD28-coated beads to induce 110 
polyclonal stimulation. T cell function was assessed by measurement of seven activation 111 
markers on CD4+ helper and CD8+ cytotoxic T cells, respectively. Secreted cytokines 112 
characteristic of T helper 1 (Th1) cell (interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-113 
α)), Th2 cell (IL-4, IL-5, IL-13), Th 17 cell (IL-17) and Tregs (IL-10) immunity were 114 
measured in supernatants. Moreover, we characterized the percentage of CD4+CD25+ T cells 115 
within unstimulated cord blood T cells. These parameters of T cell function were studied in 116 
relation to maternal parity to examine if in utero programming of the T cell compartment is 117 
influenced by birth-order.  118 
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METHODS 119 
Study population 120 
A total of 28 full-term, healthy neonates born from September 2009 to March 2010 were 121 
enrolled in this study. The neonates were part of the ongoing unselected Copenhagen 122 
Prospective Study on Asthma in Childhood 2010 birth-cohort (COPSAC2010) of 700 children 123 
recruited in Zealand, Denmark, during 2009-2010 (21). Parental atopy was defined from a 124 
history of doctor-diagnosed asthma, rhinitis, and/or atopic dermatitis. This was determined 125 
by structured clinical interviews performed by the research doctors in gestation week 24. The 126 
study was conducted in accordance with the guiding principles of the Declaration of Helsinki 127 
and approved by the Ethics Committee for Copenhagen (H-B-2008-093) and the Danish 128 
Data Protection Agency (j.nr. 2008-41-2599). Both parents gave their informed consent 129 
before enrollment of the child. 130 
Cord blood sampling and shipment 131 
Cord blood was collected postpartum by needle puncture of the umbilical vein. The blood 132 
was stored in a citrate phosphate dextrose-containing bag (catalog 791-01U, Pall, NY) and 133 
immediately transported to the laboratory by courier and processed within 24 hours after 134 
birth.  135 
T cell purification and activation 136 
Cord blood CD3+ T cells were isolated using the Dynabeads® FlowComp™ Human CD3 kit 137 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. In brief, T cells 138 
were purified from 40 x 106 total nucleated cord blood cells by positive selection using anti-139 
CD3 antibody and magnetic beads. To release CD3+ cells from beads, cells were incubated 140 
with FlowComp™ Release Buffer. For all individuals, the purity of CD3+ T cells was 141 
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determined to be greater than 98% by flow cytometry (anti-CD3/APC-eFlour780 antibody 142 
(eBioscience, San Diego, CA)). 143 
Isolated T cells were cultured (106 cells/mL, 200 ul in 96 U-bottomed plates) and activated 144 
using Dynabeads® Human T-Expander CD3/CD28 (Invitrogen) in complete medium (RPMI 145 
1640 containing 2 mM L-glutamine, 10% heat-inactivated fetal bovine serum, 100 U/mL 146 
penicillin, 100 ug/mL streptomycin (all from Lonza)). Control conditions were unstimulated 147 
T cells. Cultures were kept in a humidified 37°C, 5% CO2 incubator for 24h.  148 
T cell activation markers  149 
T cell surface expression of activation markers CD25, CD27, CD30, CD69, CD71, CD154 150 
(CD40L) and CD278 (ICOS) was determined on CD3+CD4+ helper and CD3+CD8+ 151 
cytotoxic T cells following activation. 4 x 105 T cells were stained in FACS buffer (PBS, 152 
0.1% sodium azide, 1 % heat-inactivated fetal bovine serum for 30 min at 4˚C using the 153 
following antibodies: Fluorescein isothiocyanate (FITC)-conjugated anti-hCD71, R-154 
Phycoerythrin (PE)-conjugated anti-hCD69, PE-anti-hCD30, PE-Cyanin 7 (PE-Cy7)-155 
conjugated anti-hCD278, allophycocyanin eFluor 780 (APC-eFlour780)-anti-hCD3, eFlour 156 
450-conjuated anti-hCD4 (all from eBioscience), R-Cy7-anti-hCD25 (Beckman Coulter, 157 
Fullerton, CA), Amcyan-conjugated anti-hCD8 (BD Biosciences, Franklin Lakes, NJ), 158 
AlexaFlour647 anti-hCD27 and AlexaFlour488 anti-hCD154 (BioLegend, San Diego, CA). 159 
Cells were analyzed on a BD FACSCantoTM II (BD Biosciences) followed by data analysis 160 
in FlowJo v.7.6.5 (Tree Star, Ashland, OR). The surface marker expression levels were 161 
determined as the mean fluorescence intensity (MFI) in both stimulated and unstimulated T 162 
cells. The percentages of CD4+CD25+ and CD8+CD25+ T cells were determined in 163 
unstimulated samples. Representative histograms of surface marker expressions before and 164 
after activation can be found in Supplementary Figure S1.  165 
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T cell effector cytokine production 166 
Supernatants were collected 24h after initiation of poly-clonal T cell activation and stored at 167 
-80˚C until analysis. The level of IFN-γ, TNF-α, IL-4, IL-5, IL-10, IL-13 and IL-17A (IL-168 
17) were measured in supernatants using a custom Meso Scale Discovery Multi-plex human 169 
cytokine assay (Meso Scale Discovery, Gaithersburg, MD). Assays were performed 170 
according to manufacturer’s recommendations, but included sample incubation over night at 171 
4°C on shaker and the use of an eight-point standard curve (0.65 - 10,000 pg/mL) for 172 
increased sensitivity and dynamic range. Samples were read using the Sector Imager 6000 173 
(Meso Scale Discovery). Detection limits were measured in pg/mL, calculated as mean of 174 
blanks + 3x standard deviation and were as follows: IFN-γ: 0.93, TNF-α: 0.66, IL-4: 0.88, 175 
IL-5: 0.65, IL-10: 0.76, IL-13: 4.1 and IL-17: 1.7. Signals from unstimulated T cells were 176 
below the detection limit. Signals below the lower detection limit were set to 0.5 x the lower 177 
detection limit and samples with zero values were set to 0.1 x the lower detection limit. For 178 
IL-4, 21% of the measurements were below the detection level, and 11% were undetectable; 179 
for IL-5, 18% of the measurements were below the detection level; for IL-17, 11% of the 180 
measurements were below the detection level and 25% were undetectable.  181 
Statistical analyses of immune mediator measurements 182 
Data was analyzed by conventional statistics and explored using principal components 183 
analysis (PCA). If needed, effector mediator levels were log-transformed before analysis to 184 
obtain normality distribution. Differences in immune mediator levels between groups by sex, 185 
maternal parity and parental atopy were tested by unpaired Student’s t-test. General linear 186 
models (GLM) were applied with immune mediator levels as dependent variables and sex, 187 
parity and parental atopy as independent covariates (Supplementary Table S1). Estimates of 188 
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scaled, adjusted dependent variables (z-scores) were expressed as differences between 189 
groups with corresponding 95% confidence intervals.  190 
PCA was applied to all 21 variables of T cell activation markers and cytokines after scaling. 191 
The first principal component (PC1) in the PCA accounts for the largest variation in the 192 
dataset; the second principal component (PC2) accounts for the second largest variation in 193 
data, and so forth. Projections of data onto PCs reveal new underlying latent variables (the 194 
scores). By use of a PCA algorithm, we obtained the PCs describing the systematic variation 195 
in data across the 21 variables; hence revealing the biological profiles that dominate the 196 
dataset. We applied the scores as dependent variables in the uni- and multivariate statistical 197 
analysis.          198 
Statistical significance was defined by P < 0.05. We used Bonferroni correction separately 199 
on the two measured compartments: cytokines and surface markers. The PCA further 200 
surpassed multiple testing issues by reducing the number of variables to a few latent factors. 201 
Data processing was performed with R v. 2.15.3 software (http://www.R-project.org, R 202 
Development Core Team, Vienna, Austria). PCA results were illustrated by use of the R 203 
add-on Ade4 package (22).  204 
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RESULTS 205 
Study population characteristics 206 
The study population is part of the COPSAC2010 cohort and included 28 full-term healthy 207 
neonates born in the period from September to March. Baseline characteristics of the 208 
neonates enrolled in the study cohort did not differ significantly from neonates of the full 209 
cohort with respect to factors that may confound the present study: sex, primiparity, maternal 210 
atopy and paternal atopy (Table 1).  211 
Birth-order influences CD25 expression and IL-10 levels in activated cord blood T cells 212 
Activated cord blood T cells from first-born infants were found to produce lower IL-10 213 
levels (P = 0.007) and display reduced CD25 expression on CD4+ helper T cells (P = 0.0003) 214 
as compared to those of later-born infants (Figure 1). None of the other T cell cytokines or 215 
activation markers differed by birth-order (Figure 1). IL-10 production and CD25 expression 216 
on CD4+ helper T cells were also found to be significantly different in first-born infants 217 
compared to those of later-born after adjusting for sex and parental atopy (Table 2 and 3). 218 
Sex and parental atopy was not associated with cytokine production or activation marker 219 
expression levels in activated cord blood T cells (Table 2 and 3). 220 
The percentage of CD4+ helper and CD8+ cytotoxic T cells within the pool of cord blood 221 
CD3+ T cells were unaffected by primiparity as well as sex and parental atopy (Table 3). The 222 
general activation characteristics and correlations between the twenty-one T cell functional 223 
parameters of activated cord blood T cells are displayed in Supplementary Figure S2-S4.  224 
We found that IL-10 levels positively correlated with the expression of CD25 on CD4+ 225 
helper T cells in activated cord blood T cells (Figure 2, P = 0.006). Consistent with the 226 
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univariate analysis in Figure 1; first-born infants displayed lower IL-10 and CD25 227 
expression compared to later-born infants (Figure 2).  228 
We then tested if increased IL-10 production and CD25 expression on CD4+ T cells was 229 
associated with enhanced numbers of resting CD4+CD25+ in cord blood that may represent 230 
Treg. An apparent CD4+CD25+ population was identifiable in unstimulated cord blood T 231 
cells (Figure 3A). As CD25 can also be a marker for recent activation, we also analyzed for 232 
CD25 expression levels on unstimulated CD8+ T cells that would be apparent if cord blood T 233 
cells were activated in vivo. No CD25 expression was found on unstimulated CD8+ T cells 234 
(Figure 3B), suggesting that the cord blood CD4+CD25+ cells represent a Treg subset, and 235 
not readily activated T cells present within cord blood. When comparing the percentage of 236 
circulating cord blood CD4+CD25+ cells in first-born and later-born infants, we found no 237 
differences (Table 3). However, the percentage of cord blood CD4+CD25+ cells was found to 238 
correlate positively with the levels of secreted IL-10 in activated T cells (P = 0.006, Figure 239 
3C), and also with TNF-α (P = 0.0006), IL-13 (P = 0.0008), IL-5 (P = 0.048), and IL-4 (P = 240 
0.012) (data not shown), but all these correlations were independent of birth-order (Figure 241 
3C). 242 
The birth-order affects the general profile of activated cord blood T cells 243 
In support of the conventional statistics, the PCA identified differences in overall surface 244 
marker and cytokine response levels between first-born and later-born neonates, respectively 245 
(Figure 4). Principal Component (PC) 1 was found to explain 27% of the variation in the 246 
data and to separate overall cytokines from surface markers (PC1, Figure 4B), but these 247 
patterns remained largely similar in first-born and later-born infants (PC1, Figure 4E). On 248 
the other hand, PC2, which explained 18% of the data variation, showed to separate T cell 249 
immunity in first-born and later-born infants (P=0.02, PC2, Figure 4E). Uniting the score 250 
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plot (Figure 4A) and loading plot (Figure 4B) for PC1 and PC2 again illustrated the 251 
correlation of IL-10 and CD4+CD25+ and their combined impact on the separation by 252 
maternal parity.   253 
PC3, explaining 15% of the variation in data, appeared to cluster Th2 markers (CD30, 254 
CD278, IL-4, IL-5, IL-13), Treg (CD25, IL-10) and Th17 (IL-17), while separating them 255 
from Th1 markers (IFN-γ, TNF-α, CD154 and early activation (CD69)) (PC3, Figure 4C & 256 
D). PC3 did not relate to the birth-order (Figure 4E).  257 
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DISCUSSION 258 
Main findings 259 
We identified a functional divergence in activated cord blood T cells relating to birth-order. 260 
T cells from first-born children exhibited reduced IL-10 production and CD25 expression on 261 
CD4 helper T cells following activation. This weakened anti-inflammatory profile in higher 262 
birth-order newborns did not relate to the relative number of resting cord blood CD4+CD25+ 263 
T cells. Our findings imply that first-born newborns possess a T cell compartment that is 264 
programmed at birth to respond with lower IL-10 and CD25 expression in CD4+ T cells upon 265 
stimulation as compared to second or later born children. Such changes could likely impact 266 
immune function and handling of environmental exposures during early life, and may as 267 
such influence later disease risk in first-born offspring.  268 
 269 
Study strengths and limitations 270 
It is a strength of this study that we used purified cord blood T cells allowing us to examine 271 
in utero imprinted properties of the T cell compartment without inference from other 272 
immune cells present in cord blood (23). Accordingly, we were able to document a clear in 273 
utero imprinting of the functional response from T cells by birth-order. To our knowledge 274 
this has not previously been demonstrated. We used anti-CD3/28-coated beads to 275 
polyclonally activate all subtypes of cord blood T cells. These beads mimic antigen-276 
presenting cells and are believed to activate T cells in a physiological manner compared to 277 
more commonly used agents like Staphylococcus enterotoxin B, PMA/ionomycin and 278 
phytohemagglutinin (PHA). Addressing several T cell parameters such as T cell cytokines 279 
and surface activation marker expression allowed us, in a comprehensive manner, to identify 280 
specific functional entities affected by parity number. We tested for seven different 281 
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cytokines that promote immunity to intracellular pathogens (type-1; IFN-γ, TNF-α), 282 
extracellular pathogens (type-17; IL-17), helminthes (type-2; IL-4, IL-5, IL-13), as well as 283 
immune regulation (IL-10). These cytokine measures were combined with identification of 284 
the level of expression of seven surface markers on activated T cells (CD25, CD27, CD30, 285 
CD69, CD71, CD154, CD278) that are all enhanced during proliferation, but of which we 286 
have yet limited insight into in regard to their exact involvement in specific types of immune 287 
responses. 288 
Based on our present finding pointing towards a reduced anti-inflammatory function in first-289 
born newborns, it is a limitation that we did not perform a detailed characterization of Tregs 290 
in the cord blood of these newborns. Although no human lineage specific marker of Treg 291 
exists (24), CD25hiFoxP3+CD127lo are generally accepted as markers of Tregs (24). As we 292 
did not look specifically for Treg identification in this study, we had only data available for 293 
CD25. We therefore used CD25 expression patterns in unstimulated cord blood T cells to 294 
make a proxy for the percentage of Tregs (identified as CD4+CD25+) in cord blood. CD25 is 295 
constitutively expressed on Tregs, whereas activated effector T cells up-regulate CD25 296 
expression. Since we observed no activation of CD8+ T cells in unstimulated cord blood, we 297 
used this observation to imply that the number of recently activated effector CD4+ T cells 298 
(with CD25+) would accordingly be low in the cord blood of these infants. This is in line 299 
with earlier studies that have identified only very few activated T cells in cord blood (25). 300 
Thus, we assumed that the CD4+CD25+ subset identified here represent cord blood Tregs. 301 
This is further supported by a comparable percentage of CD4+CD25+ Treg cells in a previous 302 
study (26).  303 
 304 
Interpretation 305 
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Our current finding supports the assumption that T cell functional properties of the newborn 306 
immune response are programmed in utero (27–29), and that birth-order may influence these 307 
priming events (27,30). We demonstrate that first-born infants display a reduced anti-308 
inflammatory profile in T cells at birth. This suggests that immune regulatory mechanisms 309 
inducing maternal-fetal tolerance in the mother during pregnancy affects immune function in 310 
the offspring. This notion is also supported by a previous study showing a correlation of 311 
anti-inflammatory, but not pro-inflammatory, cytokines between mother and child (19).  312 
The pleiotropic cytokine IL-10 that was decreased in activated T cells from first-born 313 
neonates has significant immune-modulatory properties affecting a broad range of immune 314 
and non-immune cells (reviewed in (31,32)). IL-10 is well-known for its repression of pro-315 
inflammatory responses and limitation of inflammation-induced tissue disruption. A recent 316 
study, suggests that IL-10 itself may be important for Treg homeostasis in pregnancy (19). 317 
This may explain our current finding of a general correlation between the percentage of 318 
CD4+CD25+ cells in cord blood T cells and the secretion of IL-10 from stimulated T cells, 319 
irrespective of parity. 320 
Up-regulation of CD25 (IL2Rα) expression is necessary for proliferation and differentiation 321 
of naïve T cells into effector T cells upon antigenic activation by antigen-presenting cells. 322 
Enhanced CD25 expression levels on CD4+ T cells, without concomitant increase in other 323 
markers, is indicative of improved activity of a specific subset of CD4+ T cells with 324 
suppressive properties (reviewed in (24,33)). Indeed, Tregs can suppress activation of by-325 
stander T cells by up-regulating CD25 expression to scavenge IL-2 important for expansion 326 
of pro-inflammatory T cells. We observed an increased CD25 expression on CD4+ T cells 327 
and an enhanced IL-10 secretion into culture medium, and speculate that a specific Treg cell 328 
subset could be responsible for this phenotype. One such subset could be the induced IL-10-329 
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producing Tr1 subset that is itself promoted by IL-10 (34). Although it remains to be 330 
demonstrated, we speculate that transfer of the anti-inflammatory pregnancy milieu from 331 
mother to fetus may promote induction of regulatory Tr1 cells in the offspring, and that this 332 
specific subset may increase by birth-order. However, based on our exploratory experimental 333 
setup, we did not specifically examine the expansion and function of certain Treg 334 
populations. It will be of great interest to delineate this in future studies, since elucidation of 335 
the basis of in utero regulatory mechanisms could be of central importance to understand the 336 
reduced disease risk in higher-birth-order infants. We also speculate that enhanced IL-10 337 
secretion from activated T cells after birth could confer some protection against excessive 338 
tissue pathology after exposure to infectious microbes, as well as increasing the level of 339 
peripheral tolerance to self and non-self antigens (35). Such disease-protective mechanisms 340 
could play part in the reduced disease risk seen in higher-birth-order infants (1).  341 
It is widely believed that the birth-order-effect on disease risk arises due to postnatal 342 
exposures associated with having older children in the household, conceptualized by the 343 
hygiene hypothesis (36). The possibility of effects related to in utero priming of immunity as 344 
a cause of previous carriage of older siblings has received less attention. In the current study, 345 
we show that in utero priming of a T cell functional bias occurs before postnatal exposure to 346 
older siblings/children. Whether the factors mediating this effect is related to enhanced 347 
maternal exposure to infections during pregnancy (due to a higher microbial burden carried 348 
by older siblings), as proposed by Karmaus et al. (30), by feto-maternal communication of 349 
immunosuppressive mechanisms as a cause of the increased number of Tregs specific for 350 
paternal antigens found in secondary pregnancies (18), or by yet unidentified mechanisms 351 
still remain to be demonstrated. Based on our current results, it will however, be of interest 352 
to increase the focus on elucidation of the underlying mechanism as well as its contribution 353 
to in utero immune priming in shaping the risk of birth-order-affected diseases.    354 
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In conclusion, our present finding of decreased IL-10 secretion and CD25 expression on 355 
CD4+ helper T cells in first-born children demonstrates that programming of T cells takes 356 
place in utero and depends on the number of maternal pregnancies. This finding may 357 
partially explain the enhanced risk of developing immune-related diseases in first-born 358 
individuals.    359 
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TABLES & FIGURES 468 
Table 1. Characteristics of the study population.  469 
 
 
Study cohort 
 
n = 28 
COPSAC2010 cohort 
 
n = 618  
P-valuea 
 
Sex (n(%)) 
   Male  
   Female 
 
 
 
17 (61%) 
11 (39%) 
 
 
313 (51%) 
305 (49%) 
 
 
 
0.338 
Parity (n(%)) 
   Primi  
   Multi 
 
 
14 (50%) 
14 (50%) 
 
 
293 (47%) 
325 (53%) 
 
 
0.848 
Maternal Atopy (n(%)) 
   Yes 
   No  
 
 
18 (64%) 
10 (36%) 
 
295 (48%) 
323 (52%) 
 
 
0.248 
Paternal Atopy (n(%)) 
   Yes 
   No  
 
 
10 (36%) 
18 (64%) 
 
346 (56%) 
272 (44%) 
 
 
0.440 
aFisher’s exact test  470 
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Table 2. Influence of prenatal factors on cytokine secretion in activated cord blood T cells of 471 
healthy neonates. 472 
 
IFN-γa 
(pg/mL) 
IL-10a 
(pg/mL) 
IL-4b 
(pg/mL) 
IL-5a 
(pg/mL) 
IL-13a 
(pg/mL) 
IL-17b 
(pg/mL) 
TNF-αa 
(pg/mL) 
 
Sex 
   Male (n = 17) 
   Female (n = 11) 
   P-value 
   Adj. P-valuec 
 
 
 
75.4 
98.5 
0.905 
0.963 
 
 
22.9 
26.0 
0.395 
0.300 
 
 
2.2 
3.9 
0.430 
0.653 
 
 
1.9 
2.2 
0.667 
0.761 
 
 
259 
254 
0.605 
0.872 
 
 
3.0 
4.2 
0.611 
0.831 
 
 
 
1010 
1266 
0.314 
0.246 
Parity 
   Primi (n  = 14) 
   Multi (n  = 14) 
   P-value 
   Adj. P-valuec 
 
 
100.6 
68.4 
0.482 
0.405 
 
18.0 
30.2 
0.007d 
0.011 
 
1.9 
3.7 
0.069 
0.105 
 
1.5 
2.6 
0.170 
0.198 
 
207 
307 
0.067 
0.170 
 
2.9 
4.1 
0.246 
0.378 
 
1055 
1167 
0.636 
0.746 
 
Maternal Atopy 
   Yes (n = 18) 
   No (n = 10) 
   P-value 
   Adj. P-valuec 
 
 
81.2 
90.5 
0.638 
0.766 
 
26.0 
20.6 
0.573 
0.940 
 
3.3 
2.0 
0.524 
0.650 
 
2.3 
1.6 
0.670 
0.585 
 
297 
185 
0.068 
0.541 
 
3.5 
3.6 
0.832 
0.946 
 
1146 
1048 
0.679 
0.511 
Paternal Atopy 
   Yes (n = 10) 
   No (n = 18) 
   P-value 
   Adj. P-valuec 
 
69.8 
92.7 
0.496 
0.634 
 
19.9 
26.5 
0.475 
0.720 
 
1.7 
3.5 
0.286 
0.306 
 
1.4 
2.4 
0.160 
0.197 
 
195 
291 
0.095 
0.377 
 
3.3 
3.6 
0.912 
0.668 
 
1090 
1123 
0.846 
0.797 
aP-value (unadjusted) calculated using Unpaired Student’s t-test,  473 
bP-value (unadjusted) calculated using Mann-Whitney-Wilcoxon test, 474 
cP-values adjusted for possible confounders (sex, parity, parental atopy) calculated using 475 
General Linear Models, 476 
dP-value = 0.05 after Bonferroni correction 477 
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Table 3. Influence of prenatal factors on percentages CD4+, CD4+CD25+ and CD8+, respectively; and surface marker expressions in activated 478 
cord blood T cells of healthy neonates.  479 
 
CD4+ 
Un-
stimulated 
(%) 
CD4CD25+ 
 
(%) 
CD71 
 
(MFI) 
CD69a 
 
(MFI) 
CD25 
 
(MFI) 
CD154a 
 
(MFI) 
CD30 
 
(MFI) 
CD278 
 
(MFI) 
CD27 
 
(MFI) 
CD8+ 
Un-stimulated 
(%) 
CD71 
 
(MFI) 
CD69 
 
(MFI) 
CD25 
 
(MFI) 
CD154 
 
(MFI) 
CD30a 
 
(MFI) 
CD278 
 
(MFI) 
CD27 
 
(MFI) 
 
Sex 
   Male (n = 17) 
   Female (n = 11) 
   P-value 
   Adj. P-valuec 
 
 
 
68.3 
73.9 
0.063 
0.225 
 
 
 
8.6 
8.1 
0.594 
0.958 
 
 
12297 
12419 
0.894 
0.858 
 
 
10216 
10443 
0.817 
0.998 
 
 
33935 
36209 
0.227 
0.064 
 
 
1834 
1883 
1.000 
0.961 
 
 
255 
237 
0.670 
0.871 
 
 
25712 
27646 
0.382 
0.289 
 
 
36424 
39755 
0.134 
0.256 
 
 
27.5 
21.5 
0.048 
0.199 
 
 
 
13295 
13114 
0.881 
0.819 
 
 
3812 
4159 
0.445 
0.457 
 
 
51571 
57727 
0.041 
0.054 
 
 
766 
792 
0.881 
0.536 
 
 
 
100 
133 
0.926 
0.489 
 
 
15263 
17536 
0.204 
0.269 
 
 
52694 
56009 
0.213 
0.214 
Parity 
   Primi (n = 14) 
   Multi (n = 14) 
   P-value 
   Adj. P-valuec 
 
 
69.8 
71.1 
0.660 
0.301 
 
7.7 
9.2 
0.113 
0.275 
 
12505 
12185 
0.723 
0.880 
 
9517 
11093 
0.210 
0.201 
 
31864 
37793 
0.0003d 
0.0005 
 
1896 
1809 
0.701 
0.716 
 
 
233 
263 
0.470 
0.682 
 
25143 
27800 
0.215 
0.297 
 
38029 
37436 
0.789 
0.837 
 
25.6 
24.7 
0.772 
0.374 
 
 
13463 
12983 
0.693 
0.902 
 
3628 
4268 
0.144 
0.179 
 
52057 
55921 
0.200 
0.138 
 
814 
738 
0.650 
0.942 
 
105 
122 
0.603 
0.516 
 
15334 
16979 
0.350 
0.337 
 
54293 
53700 
0.822 
0.911 
Maternal Atopy 
   Yes (n = 18) 
   No (n = 10) 
   P-value 
   Adj. P-valuec 
 
 
68.6 
74.0 
0.078 
0.106 
 
 
9.1 
7.3 
0.074 
0.215 
 
11775 
13371 
0.081 
0.438 
 
10320 
10278 
0.981 
0.490 
 
35317 
33950 
0.480 
0.610 
 
1839 
1878 
0.944 
0.515 
 
265 
218 
0.272 
0.629 
 
16121 
16220 
0.540 
0.611 
 
53478 
54930 
0.090 
0.507 
 
27.1 
21.6 
0.078 
0.081 
 
 
12790 
14005.7 
0.337 
0.849 
 
4021 
3816 
0.660 
0.850 
 
53456 
54950 
0.640 
0.886 
 
672 
963 
0.088 
0.052 
 
108 
123 
0.944 
0.504 
 
16121 
16220 
0.957 
0.754 
 
53478 
54930 
0.597 
0.684 
Paternal Atopy 
   Yes (n = 10) 
   No (n = 18) 
   P-value 
   Adj. P-valuec 
 
70.8 
70.3 
0.862 
0.494 
 
8.0 
8.7 
0.505 
0.758 
 
13568 
11665 
0.035 
0.200 
 
9691 
10646 
0.555 
0.408 
 
34540 
34989 
0.817 
0.585 
 
1721 
1926 
0.724 
0.236 
 
224 
262 
0.384 
0.721 
 
25800 
26844 
0.645 
0.965 
 
39730 
36622 
0.172 
0.441 
 
25.4 
25.0 
0.921 
0.306 
 
14486 
12523 
0.115 
0.263 
 
3638 
4120 
0.296 
0.423 
 
54150 
53900 
0.938 
0.870 
 
780 
774 
0.975 
0.262 
 
101 
120 
0.555 
0.449 
 
15280 
16643 
0.460 
0.500 
 
55530 
53144 
0.383 
0.362 
aP-value (unadjusted) calculated using Unpaired Student’s t-test, bP-value (unadjusted) calculated using Mann-Whitney-Wilcoxon test, cP-values adjusted for possible 480 
confounders (sex, parity, parental atopy) calculated using General Linear Models, dP = 0.004 after Bonferroni correction  481 
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 482 
Figure 1. Differences in cytokine levels and surface marker expressions in activated cord 483 
blood T cells from healthy first-born infants versus later-born infants. Scaled, adjusted 484 
dependent variables (z-scores) expressed as differences between groups with corresponding 485 
95% confidence interval. Statistical analysis by GLM with sex, parity and parental atopy as 486 
covariates. *, P < 0.05; ***, P < 0.001. CD154 (CD40L); CD278 (ICOS).   487 
Kragh, 28 
 
 488 
Figure 2. Correlation of CD25 expression on CD4+ T cells and secreted IL-10 in activated 489 
cord blood T cells of healthy first-born infants and later-born infants. IL-10 data are log-490 
transformed. Pearson’s correlation analysis was used to calculate statistics.  491 
Kragh, 29 
 
 492 
 493 
 494 
Figure 3. Presence of CD4+CD25+ cells in un-stimulated cord blood T cells of healthy 495 
neonates. A. Gating of CD4+CD25+ cells B. Gating of CD8+CD25+ cells. A-B. Cord blood T 496 
cells were isolated as described in METHODS. One representative analysis out of 28 is 497 
shown. C. Correlation of the percentage of CD4+CD25+ in un-stimulated cord blood T cells 498 
and secreted IL-10 in activated cord blood T cells of healthy first-born infants and later-born 499 
A B 
C 
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infants. IL-10 levels are log-transformed. Pearson’s correlation analysis was used to 500 
calculate statistics.  501 
Kragh, 31 
 
 502 
Figure 4. Principal component analysis of the combined immune profiles of activated cord 503 
blood T cells across first-born and later-born neonates. A, C. Score-plots grouped by birth-504 
order. Principal components (PCs) are plotted using the ade4 package in R with each 505 
Kragh, 32 
 
newborn represented by a symbol. The mean of each birth-order group is the center of the 506 
ellipse and the colored area covers 67% of the samples belonging to this group. B, D. 507 
Loading-plots illustrate the systematic distribution of immune mediators determined by PCs. 508 
In cases where expression of a given activation marker were similar on CD4 and CD8 cells, 509 
only the marker name is indicated. E. Statistics on PCs divided by parity. Data are scaled, 510 
adjusted PCs (z-scores) based on a GLM with sex, parity and parental atopy as covariates; 511 
and expressed as differences between groups with corresponding 95% confidence interval. *, 512 
P < 0.05.   513 
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SUPPLEMENTARY 514 
Table S1. Data on sex of baby; maternal and paternal atopy by parity status 515   516 
Parity Sex  Maternal atopy Paternal atopy 
Primi (n=14) 6 females 
8 males 
1 
6 
3 
3 
    
Multi (n=14) 5 females 
9 males 
4 
7 
1 
3 
 517 
  518 
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Figure S1. Activation propensity of the neonatal T cell compartment. 519 
To explore the activation propensity of isolated neonatal CD4+ and CD8+ T cells at birth, we 520 
profiled the polyclonal response to anti-CD3/CD28 using multicolor flow cytometry. Our 521 
profile included early activation markers CD69, CD71, CD25 (aIL2-R) as well as CD27, 522 
CD30, CD154 (CD40L) and CD278 (ICOS). Upon polyclonal stimulation, we measured a 523 
complete activation of both CD4+ and CD8+ T cells with 1.6 – 4000 fold changes in surface 524 
marker expression level dependent on the marker. Data shows representative histograms of 525 
surface marker expression levels before and after polyclonal activation of cord blood CD4+ 526 
and CD8+ T cells for 24h. 527 
 528 
 529 
 530 
  531 
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Figure S2. Correlation matrix of surface marker expression levels in activated cord blood 532 
CD4+ and CD8+ T cells of healthy neonates. Data show regression lines and Pearson 533 
correlation statistics: *, P < 0.05, **, P < 0.01; ***P < 0.001.  534 
 535 
  536 
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Figure S3. Relatedness of activation markers and effector cytokines expressed in 537 
activated cord blood T cells. Data show correlation matrix of cytokine and CD4+ surface 538 
marker expression levels in activated cord blood T cells of healthy neonates. Shown are 539 
regression lines and Pearson correlation statistics: *, P < 0.05, **, P < 0.01; ***P < 0.001. 540 
 541 
 542 
  543 
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Figure S4. Correlation matrix of cytokine and CD8+ surface marker expression levels 544 
in activated cord blood T cells of healthy neonates. Data display regression lines and 545 
Pearson correlation statistics: *, P < 0.05, **, P < 0.01; ***P < 0.001. 546 
 547 
